Ocular gets mixed FDA panel review for post-surgical sealant

09/20/2013 | MassDevice.com (Boston)

An FDA panel has voted in favor of recommending the safety of Ocular Therapeutix's ReSure Sealant, a topical hydrogel designed to temporarily close corneal incisions in patients who have undergone intraocular lens placement or cataract surgery. The panel, however, reached a split decision on the device's efficacy as well as on whether its benefits surpass the risks.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA